MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ESPR
  4. News
ESPR
Quote
Short
News
Articles
Message Board

Esperion Therapeutics Inc. (NASDAQ : ESPR ) News

Esperion Therapeutics Inc. (NASDAQ: ESPR) News Releases

ESPR News Releases
ESPR : NASDAQ
Business Wire
ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
ESPR : NASDAQ
SeekingAlpha
Esperion jumps on $1.1 billion ARCHIMED buyout
ESPR : NASDAQ
GlobeNewswire
Esperion to be Acquired by ARCHIMED
ESPR : NASDAQ
GlobeNewswire
Esperion to Report First Quarter 2026 Financial Results on May 7
ESPR : NASDAQ
Investing News Network
5 Best-performing Canadian Pharma Stocks in 2026
ESPR : NASDAQ
GlobeNewswire
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
ESPR : NASDAQ
GlobeNewswire
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst(TM) (bumetanide nasal spray)
ESPR : NASDAQ
GlobeNewswire
Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference
ESPR : NASDAQ
SeekingAlpha
Merck oral PCSK9 enlicitide shows improved cholesterol lowering vs. non-statins
ESPR : NASDAQ
GlobeNewswire
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology's Annual Scientific Session 2026
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.